U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403084) titled 'Post-market Clinical Follow-up Study of NEMOST V2' on Jan. 28.
Brief Summary: The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.
As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.
Retrospective and prospective multicenter post-market surveillance clinical study.
This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year po...